News from Cepheid A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Jul 06, 2015, 07:00 ET

Cepheid Schedules 2015 Second Quarter Results Announcement And Webcast

  Cepheid (Nasdaq: CPHD) today announced that it will report financial results for its 2015 second quarter ended June 30, 2015 on Thursday,...

Jun 09, 2015, 07:00 ET

Cepheid Announces Analyst Event And Webcast

 Cepheid (Nasdaq: CPHD) today announced that the company will host a Financial Analyst Event on Monday, July 27th at the 2015 AACC Meeting...

May 13, 2015, 07:00 ET

WHO Lists Cepheid's Xpert Ebola as Eligible for Procurement to Ebola Affected Countries

Cepheid (Nasdaq: CPHD) today announced that the World Health Organization (WHO) has assessed and listed Xpert® Ebola as eligible for...

May 07, 2015, 16:19 ET

Cepheid to Webcast Upcoming Financial Presentations

 Cepheid (NASDAQ: CPHD) today announced that its executives will be speaking at the following conferences, and invited investors to participate...

Apr 23, 2015, 16:05 ET

Cepheid Reports 2015 First Quarter Results

 Cepheid (Nasdaq: CPHD) today reported revenue for the first quarter of 2015 of $132.6 million, representing growth of 24% from $106.9 million...

Apr 16, 2015, 07:00 ET
Xpert HIV-1 Qual, a qualitative 90-minute molecular HIV test, has achieved CE-IVD status under the European Directive on In Vitro Diagnostic Medical Devices

Cepheid and FIND Announce European Approval of Xpert HIV-1 Qual

 Cepheid (Nasdaq: CPHD) and FIND today announced that Xpert® HIV-1 Qual, a qualitative 90-minute molecular HIV test, has achieved CE-IVD...

Apr 15, 2015, 07:00 ET

Cepheid Announces European Approval of Xpert HCV Viral Load

 Cepheid (NASDAQ: CPHD) today announced that Xpert® HCV Viral Load, a quantitative test that provides on-demand molecular testing for...

Apr 07, 2015, 16:07 ET

Cepheid Welcomes Executive Vice President And Chief Financial Officer

 Cepheid (Nasdaq: CPHD) today announced that it has appointed Mr. Ilan Daskal to the position of Executive Vice President and Chief Financial...

Apr 07, 2015, 16:05 ET

Cepheid Schedules 2015 First Quarter Results Announcement And Webcast

Cepheid (Nasdaq: CPHD) today announced that it will report financial results for its 2015 first quarter ended March 31, 2015 on Thursday, April 23,...

Mar 24, 2015, 16:05 ET

Cepheid Receives Emergency Use Authorization from FDA for Xpert Ebola Diagnostic Test

 Cepheid (Nasdaq: CPHD) today announced it has received Emergency Use Authorization from the U.S. Food & Drug Administration (FDA) for...

Mar 24, 2015, 07:00 ET

On World TB Day 2015 Cepheid and NHLS Commemorate Global Shipment of the 10 Millionth Xpert MTB/RIF Test Cartridge

 Cepheid (Nasdaq: CPHD) and the National Health Laboratory Service (NHLS) in South Africa today recognized World TB Day 2015 by commemorating...

Feb 18, 2015, 16:05 ET

Cepheid to Webcast Upcoming Financial Presentations

 Cepheid (NASDAQ: CPHD) today announced that its executives will be speaking at the following conferences, and invited investors to participate...

Feb 13, 2015, 07:00 ET

Cepheid Receives FDA Clearance for Expanded Claims on Tuberculosis Test

 Cepheid (Nasdaq: CPHD) today announced it has received clearance from the U.S. Food & Drug Administration (FDA) for expanded claims on its...

Jan 29, 2015, 16:05 ET

Cepheid Reports Fourth Quarter And Full Year 2014 Results

 Cepheid (Nasdaq: CPHD) today reported revenue for the fourth quarter of 2014 of $131.5 million.  Net...

Jan 05, 2015, 08:00 ET

Cepheid Announces CFO Change

Cepheid (Nasdaq: CPHD) today announced that Andrew Miller, executive vice president and chief financial officer, will be leaving Cepheid to pursue...

Dec 29, 2014, 07:00 ET

Cepheid and FIND Announce European Approval of Xpert HIV-1 Viral Load

Cepheid (Nasdaq: CPHD) and the Foundation for Innovative New Diagnostics (FIND) today announced that Xpert® HIV-1 Viral Load, a quantitative...

Dec 01, 2014, 07:00 ET

Cepheid Receives FDA Clearance for Xpert Norovirus, the First On-Demand Molecular Test for Detection of Norovirus

Cepheid (NASDAQ: CPHD) today announced it has received clearance from the U.S. Food & Drug Administration (FDA) to market Xpert®...

Nov 24, 2014, 16:05 ET

Cepheid Receives FDA Clearance for Xpert Flu/RSV XC

Cepheid (NASDAQ: CPHD) today announced it has received clearance from the U.S. Food & Drug Administration (FDA) to market its Xpert®...

Nov 20, 2014, 16:05 ET

Cepheid to Webcast Upcoming Financial Presentations

 Cepheid (NASDAQ: CPHD) today announced that its executives will be speaking at the following conferences, and invited investors to participate...

Nov 13, 2014, 07:00 ET

Cepheid To Develop Xpert Ebola For Countries Worst Hit By Epidemic

 Cepheid (NASDAQ: CPHD) today announced that it has been awarded a grant of up to $3.3 million co-financed by the Paul G. Allen Family...